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Brief Definit ive Report
The recently identified innate lymphoid cell 
(ILC) family consists of IFN-–secreting group 1 
ILCs (ILC1s), type 2 cytokine-producing ILC2s, 
and IL-22– and/or IL-17–positive ILC3s (Walker 
et al., 2013). ILC1s and ILC3s play critical roles 
in protective immunity against bacteria, intra-
cellular protozoan parasites (ILC1), and fungi 
(ILC3) and in autoimmune disorders (McKenzie 
et al., 2014). In contrast, ILC2s associate with 
immune responses to parasitic worms, allergy, 
and wound repair (McKenzie et al., 2014).
These functionally diverse cytokine-producing 
cells arise from a common lymphoid progen-
itor under the control of specific transcrip-
tional regulators (Diefenbach et al., 2014). 
These include upstream factors such as inhibi-
tor of DNA binding 2 (Id2), Notch, GATA-
binding protein 3 (GATA3), nuclear factor 
interleukin-3 (Nfil3), T cell factor 1 (TCF1), 
and promyelocytic leukemia zinc finger (PLZF) 
that restrict the differentiation of a common 
helper ILC progenitor (CHILP) from the com-
mon lymphoid progenitor (Diefenbach et al., 
2014). Downstream, lineage-specific transcrip-
tion factors are necessary for lineage commit-
ment: ILC1s require the T-box transcription 
factor T-bet (Tbx21), ILC2s require GATA3 
and transcription factor retinoic acid receptor–
related orphan nuclear receptor  (ROR), 
and ILC3s require RORt (Diefenbach et al., 
2014). Notably, the majority of factors identi-
fied in these pathways play roles in the specifi-
cation of the progenitor cells and lie proximal 
to the division of the functional ILC subsets.
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Group 2 innate lymphoid cells (ILC2s) are often found associated with mucosal surfaces 
where they contribute to protective immunity, inappropriate allergic responses, and tissue 
repair. Although we know they develop from a common lymphoid progenitor in the bone 
marrow (BM), the specific lineage path and transcriptional regulators that are involved are 
only starting to emerge. After ILC2 gene expression analysis we investigated the role of 
Bcl11b, a factor previously linked to T cell commitment, in ILC2 development. Using com-
bined Bcl11b-tom and Id2-gfp reporter mice, we show that Bcl11b is expressed in ILC2 
precursors in the BM and maintained in mature ILC2s. In vivo deletion of Bcl11b, by condi-
tional tamoxifen-induced depletion or by Bcl11b/ fetal liver chimera reconstitution, 
demonstrates that ILC2s are wholly dependent on Bcl11b for their development. Notably,  
in the absence of Bcl11b there is a concomitant expansion of the RORt+ ILC3 population, 
suggesting that Bcl11b may negatively regulate this lineage. Using Nippostrongylus brasil-
iensis infection, we reveal that the absence of Bcl11b leads to impaired worm expulsion, 
caused by a deficit in ILC2s, whereas Citrobacter rodentium infection is cleared efficiently. 
These data clearly establish Bcl11b as a new factor in the differentiation of ILC2s.
© 2015 Walker et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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and myeloid cells were negative (not depicted). ILC2s (phe-
notypic analysis and gating strategies in Figs. S1 and S2), 
isolated from ILC2-associated immunological sites in naive 
mice, also expressed Bcl11b-tom similar to T cells (Fig. 1, a–c). 
Bcl11b-tom expression was reduced slightly in ILC2s after 
in vivo stimulation with IL-25 and IL-33 (Fig. 1, c and d); 
the reason for this is unclear. Thus, mature ILC2s express 
high amounts of Bcl11b in the peripheral lymphoid tissues. 
Bcl11b-tom expression was also detected in ILC2-like cells 
in the BM, suggesting that it may be present in ILC2 pre-
cursors (ILC2ps; Fig. 1 e). Notably, Bcl11b-tom was also 
expressed heterogeneously in a proportion of non-LTi ILC3s 
from the small intestine lamina propria (siLP; Fig. 1 f and 
Fig. S2 a).
Characterization of a Bcl11b-expressing ILC2ps
Because mature ILC2s arise from ILC2ps in the BM, we 
sought to identify whether ILC2ps express Bcl11b. We iden-
tified BM-derived ILC2ps (ICOS+) using mice in which Id2 
expression, which marks early NK progenitors (Carotta et al., 
2011) and is required for the development of all ILC subsets, 
is reported by the expression of an IRES green fluorescent 
protein (Id2gfp/+; Jackson et al., 2011), in combination with 
surface markers to exclude NK-like precursors (NKps; CD244). 
Thus, the linId2-gfp+ BM cell population was subdivided 
by ICOS and/or CD244 into four subsets (Fig. S2 b). To assess 
their lineage commitment, these cells were purified and 
plated onto OP9 or OP9–Delta-like ligand 1 (DL1) cell 
monolayers in the presence of ILC2-promoting IL-7 and 
IL-33 or NK-promoting IL-7 and IL-15. We demarcated 
ILC2ps (linId2-gfp+ICOS+CD244; Fig. 2, a and c) and NKps 
(linId2-gfp+ICOSCD244+; Fig. 2, b and c). In some in-
stances, cultures gave rise to additional populations of cells 
(CD3, CD19, CD11b, CD11c, Gr-1, NK1.1, NKp46) 
that could not be ascribed to any particular lineage. Subse-
quent analysis of intercrossed Id2gfp/+ and Bcl11btom/+ mice 
demonstrated that expression of Bcl11b-tom was almost 
mutually exclusive in the ILC2p and NKp populations, being 
expressed only by the ILC2ps, both upon direct isolation from 
the BM and after culture on OP9-DL1 feeder cells to pro-
duce ILC2s (Fig. 2, d and e).
To confirm the progenitor status of the Bcl11b+ BM cells, we 
isolated Id2-gfp+Bcl11b+ICOS+ or Id2-gfp+Bcl11bCD244+ 
BM precursor subsets and transferred these into Rag2/c/ 
recipient mice (Fig. S2, c and d). Only Id2-gfp+Bcl11b+ pre-
cursors gave rise to ILC2s upon adoptive transfer (Fig. 2 f). 
Transfer of the Id2-gfp+Bcl11b precursors gave rise to NK 
cells (Fig. 2 g). Comparison of the Id2-gfp+Bcl11b+ precur-
sors with the previously reported LinSca1hiId2hi (LSI) pre-
cursor (Fig. S2, e and f; Hoyler et al., 2012) indicated that 
they are very similar (Fig. 2 h) and give rise to phenotypically 
identical Gata3+KLRG1+ ILC2s upon adoptive transfer into 
Rag2/c/ recipients (Fig. 2, i and j). These transfers also 
generated a population of Gata3ICOS+KLRG1 cells, the 
significance of which is unclear, but that may represent im-
mature ILC2s (Fig. 2, i and j).
Although they comprise only a small proportion of the 
hematopoietic compartment, ILC2s (often at the mucosal 
borders) are a critical innate cellular source of type 2 cytokines, 
secreting copious IL-5 and IL-13, but also IL-9, IL-4, and 
GM-CSF (Moro et al., 2010; Neill et al., 2010; Price et al., 
2010). These effector cytokines potently induce eosinophilia, 
goblet cell hyperplasia and mucus production, mastocytosis, 
alternatively activated macrophages, and muscle contractility 
and contribute to tissue repair (McKenzie et al., 2014). Thus, 
ILC2s that expand in response to the type 2 initiator cyto-
kines IL-25, IL-33, and TSLP play a key role in protective im-
munity against parasitic helminth infection (Moro et al., 2010; 
Neill et al., 2010; Price et al., 2010), contribute to inappropri-
ate allergic inflammation (Barlow et al., 2011; Chang et al., 
2011; Mjösberg et al., 2011), and are associated with meta-
bolic homeostasis, obesity, and dietary stress (Hams et al., 2013; 
Molofsky et al., 2013; Stanya et al., 2013).
ILC2s can be derived from a PLZF+ fraction of CHILPs, 
and conditional deletion of GATA3 in Id2+ cells or germline 
deletion has demonstrated that GATA3 is required both for 
the development of all ILCs and for the later restriction of the 
ILC2 lineage (Hoyler et al., 2012; Yagi et al., 2014). In con-
trast, ROR-deficient mice have apparently normal CHILP 
and ILC3 production, but BM progenitors from these mice 
fail to develop into ILC2s, both in vivo and in vitro (Halim 
et al., 2012; Wong et al., 2012). In addition to ROR and 
GATA3, the transcription factor B cell leukemia/lymphoma 
11b (Bcl11b) was also reported to be up-regulated in ILC2s, 
but its role remained undefined (Wong et al., 2012). Bcl11b 
is a zinc finger transcription factor that is required at multiple 
developmental checkpoints for T cell commitment and main-
tenance (Avram and Califano, 2014). Germline deletion of 
Bcl11b results in homozygous mice dying shortly after birth 
from a complex idiopathic disease, and although hematopoiesis 
appears normal, there is a block in thymocyte development at 
the double-negative 2 (DN2) stage (Wakabayashi et al., 2003). 
These Bcl11b-deficient DN2 thymocytes were highly prolif-
erative in vivo, and although they could not develop into 
T cells, they retained the potential to differentiate into NK cells 
and myeloid lineages. Interestingly, conditional depletion of 
Bcl11b resulted in T cells acquiring an NK cell–like phenotype, 
indicating that Bcl11b is crucial for maintaining T cell com-
mitment and repressing alternative lineage choices (Li et al., 
2010b). Given the critical role of Bcl11b in T lymphocyte de-
velopment and its elevated expression in ILC2s, we investi-
gated the role of Bcl11b in ILC2 development and function.
RESULTS AND DISCUSSION
Bcl11b is expressed in ILC2 precursors  
and throughout ILC2 development
To assess the expression of Bcl11b in ILC2 populations, we 
used a Bcl11b-tdtomato (Bcl11b-tom) knock-in mouse 
(Bcl11btom/+) in which Bcl11b-tom expression acts as a surro-
gate for Bcl11b expression (Li et al., 2010b). CD4+ (Fig. 1 a) 
and CD8+ T cells (not depicted) from the mesenteric LNs 
(MLNs) were strongly positive for Bcl11b-tom, whereas B cells 
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controls, tamoxifen treatment did not alter ILC2 numbers in 
the MLNs (Fig. 3 a and Fig. S3 a), although we did observe 
a reduction in the relative frequency of ILC2s (Fig. S3 a), 
which may reflect as yet not understood changes in multiple 
cell populations. Bcl11b deletion did not affect the frequency 
of BM ILC2p (Fig. 3 b) or Gata3 expression (Fig. 3 c). We 
next examined the effect of Bcl11b depletion in the context 
of ILC2 stimulation by IL-33. Conditional Bcl11b-deficient 
(Bcl11bflox/) mice bearing an Id2-gfp allele, intercrossed with 
Rosa26Cre-ERT2 mice (Cre-ERT2; Bcl11bflox/ referred to here-
after as Bcl11bflox/), Bcl11bflox/ mice, or controls (Cre-ERT2; 
Bcl11b+/ referred to hereafter as Bcl11b+/) were treated with 
tamoxifen. After IL-33 stimulation, there were considerably 
fewer ILC2s in the MLNs of the Bcl11bflox/ mice as com-
pared with the Bcl11b+/ controls, which did not reach sta-
tistical significance but was consistent between two similar 
experiments (Fig. 3 d and Fig. S3 b). Tamoxifen administra-
tion was accompanied by a fall in the numbers of T cells in 
the absence of Bcl11b (Fig. 3 e) and a reciprocal increase in 
NK1.1+ cell numbers (Fig. 3 f), as reported previously (Li et al., 
2010b). These findings suggest that Bcl11b is not required for 
Although the majority of ICOS+CD244+ cells were 
Bcl11b, ICOSCD244 cells displayed bimodal expression 
of Bcl11b-tom (Fig. 2 k). Upon culture under ILC2- or 
NK-promoting conditions, the Bcl11b+ fraction gave rise 
exclusively to ILC2s, whereas the Bcl11b subset gave rise to 
mixed progeny (Fig. 2, l and m), suggesting that they may 
represent a mixed population of uncommitted precursors. Fi-
nally, we examined the expression of Gata3 in populations 
delineated by Id2-gfp and Bcl11b-tom and found that Gata3 
is up-regulated in Id2-expressing cells, perhaps before the in-
duction of Bcl11b (Fig. 2 n). These results demonstrate that 
Bcl11b is expressed by a lineage-restricted ILC2p and that, in 
combination with Id2, expression of Bcl11b can be used to 
purify the ILC2ps.
Deletion of Bcl11b ablates ILC2s and increases ILC3s
We next sought to determine whether Bcl11b was function-
ally important for ILC2 development or maintenance. 
Tamoxifen was used to delete Bcl11b in conditional Bcl11b-
deficient (Cre-ERT2; Bcl11bflox/flox) mice (Li et al., 2010b), 
and ILC2 frequency was analyzed 2 wk later. Relative to 
Figure 1. Bcl11b is expressed throughout the ILC2 lineage. (a–f) Bcl11b-tom in cells isolated from Bcl11btom/+ mice, assessed by flow  
cytometry. (a and b) Bcl11b-tom expression in ILC2s and CD4+ T cells from the MLN (a) and ILC2s from FALC (linCD45+KLRG1+) and siLP 
(linCD45+ICOS+KLRG1+; b) of Bcl11b+/+ and Bcl11btom/+ mice. (c and d) Bcl11b-tom expression in ILC2s from lung (c) and MLN (d) of mice with the indi-
cated genotypes after administration of IL-25 or IL-33. (e) Expression of Bcl11b-tom in BM ILC2ps (gated as shown). (f) Bcl11b-tom expression in ILC3 
subsets (as indicated) from siLP of Bcl11btom/+ mice (black). Bcl11b-tom expression in ILC2s from siLP is shown for comparison (red). (a–f) Numbers adja-
cent to boxed areas indicate the relative percentage of gated populations. Gating strategies and phenotypic analysis are presented in Figs. S1 and S2. 
Data represent at least two independent experiments with three mice per group.
878 Bcl11b is essential for ILC2 development | Walker et al.
reconstituted with CD45.1+ BM, in combination with either 
CD45.2+ Bcl11b+/+Id2gfp/+ or Bcl11b/Id2gfp/+ FL. After 6–8 
wk, there was an absence of FL donor-derived double-positive 
thymocytes in mice receiving Bcl11b/ FL (Fig. 3 g), but no 
significant difference in the numbers of FL donor-derived 
Id2-gfp+ NK cells (Fig. 3 g). Strikingly, there was a total ab-
sence of mature FL donor-derived Id2-gfp+ ILC2s from the 
the short-term maintenance of ILC2s in tissues. However, 
they raise the question of whether Bcl11b is required for ILC2 
expansion in the tissues or for the continued generation of 
ILC2ps in the BM.
To address this question and the potential issues of dosing 
and off-target effects of tamoxifen, we also generated fetal 
liver (FL) chimeras in which irradiated CD45.2+ hosts were 
Figure 2. Bcl11b expression defines ILC2ps in the BM. (a–n) ICOS+CD244 (ILC2p), ICOS+CD244+, ICOSCD244+ (NKp), and ICOSCD244 subsets were 
isolated from linId2-gfp+ BM cells and cultured in vitro (a–c, e, l, and m) or adoptively transferred into alymphoid recipients (f, g, i, and j) to assess their 
lineage potential; flow cytometry of linId2-gfp+ subsets (d, h, k, and n) is shown. (a and b) The phenotype of the indicated cell populations cultured for 11 d 
on OP9-DL1 stromal cells in the presence of IL-7 and IL-33 (a) or cultured for 11 d on OP9 stromal cells in the presence of IL-7 and IL-15 (b). (c) Cells (1,000 
per well) were cultured for 11 d under the conditions indicated. Bar graph depicts the number of cells in the final culture represented by ILC2s  
(Id2-gfp+ICOS+) and NK cells (NKp46+NK1.1+). Shown are mean ± SEM pooled from two independent experiments with two to three technical replicates 
per group. (d) Bcl11b-tom expression in ILC2p (linId2-gfp+ICOS+CD244) and NKp (linId2-gfp+ICOSCD244+) cells. (e) Bcl11b-tom expression in ILC2ps 
after culture on OP9-DL1 stromal cells for 13 d in the presence of IL-7 and IL-33. (f and g) ILC2ps (f) and NKps (see Fig. S2 c for gating; g) were adoptively 
transferred into Rag2/c/ recipients (700 cells per recipient). Plots show flow cytometric analysis of progeny, identified by Id2-gfp+ expression 
(Fig. S2 d), from spleen at 3 wk after transfer. (h) Surface marker expression of NKp, ILC2p, and LSI progenitor cell populations, gated as indicated in  
Fig. S2 e. (i and j) Approximately 700 ILC2p (linFlt3Id2-gfp+ICOS+Bcl11b+) or LSI (linSca-1+Id2-gfp+) cells (see Fig. S2 f for gating) were adoptively 
transferred into Rag2/c/ recipients. Plots show flow cytometric analysis of progeny, identified by Id2-gfp+ expression, from siLP at 6 wk after transfer (i),  
and panel j shows intracellular Gata3 staining of progeny. (k) Bcl11b-tom expression in ICOSCD244 and ICOS+CD244+ subsets. (l and m) The phenotype of 
Bcl11b and Bcl11b+ fractions of the ICOSCD244 population, after culture for 11 d on OP9-DL1 stromal cells in the presence of IL-7 and IL-33 (l) or on 
OP9 stromal cells in the presence of IL-7 and IL-15 (m). (n) Intracellular Gata3 staining was assessed on lin BM cells, sorted as indicated. (d, h, and k) 
Data represent at least three independent experiments with at least three mice per group. (a–c, e, l, and m) Data represent two independent experiments 
with two to three technical replicates per group. (f, g, and i) Data represent two independent experiments with three mice per group. (j) Data represent  
a single experiment using cells pooled from three mice. (n) Data represent two independent experiments using cells pooled from three mice.
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(Fig. 4 a) and cleared the majority of their worms by day 7 
postinfection (p.i.; Fig. 4 b). In contrast, mice receiving 
Rorasg/floxIl7rCre/+ BM failed to produce ILC2s or clear their 
worm burden by day 7 (Fig. 4, a and b). Reconstitution with 
Bcl11b/ FL in the MLNs, as compared with wild type 
(Fig. 3 h and Fig. S3 c). Furthermore, Bcl11b/-derived 
ILC2s could not be induced by treatment with IL-33 (Fig. 3 h 
and Fig. S3 c) or IL-25 (not depicted). There were also no 
detectable FL donor-derived Id2-gfp+ ILC2ps in the BM 
(Fig. 3 i and Fig. S3 d). Notably, analysis of ILCs in 
the siLP and MLN showed that the Bcl11b/ donor cells 
gave rise to a disproportionately large population of NCR+ 
ILC3s as compared with wild type (Fig. 3, j and k; and 
Fig. S3 e).
Thus, Bcl11b is essential for the development of ILC2ps 
and consequently mature peripheral ILC2s. The complete 
absence of ILC2s in these mice is striking because residual 
ILCs have been observed after deletion of many of the previ-
ously reported factors that are important for ILC develop-
ment. Indeed, even in the absence of ROR a basal level of 
ILC2s can be detected in the peripheral tissues (Wong et al., 
2012). This implies that Bcl11b may act upstream of ROR 
during ILC2 development, although genetic complementa-
tion systems would be required to confirm this relationship.
We noted that although the absence of Bcl11b resulted 
in the loss of ILC2s, its absence also caused a reciprocal in-
crease in the numbers of ILC3s in the siLP. This suggests that 
Bcl11b may act cell-intrinsically to repress ILC3 differentia-
tion and that deletion of Bcl11b results in de-repression of 
the ILC3 program, leading to their expansion, or that the 
absence of ILC2s results in an expansion of ILC3s through 
cell-extrinsic factors.
Bcl11b-deficient progenitors fail to provide ILC2s  
during Nippostrongylus brasiliensis infection
ILC2s play critical roles in immunity to infection with para-
sitic helminths, such as N. brasiliensis. Consequently, mice 
deficient in the ILC2-inducing cytokines IL-25 and IL-33 
(Neill et al., 2010) or the transcription factor ROR (Wong 
et al., 2012; Oliphant et al., 2014) have impaired worm clear-
ance. To confirm that the deletion of Bcl11b resulted in the 
absence of functional ILC2s in vivo, and not for example a 
loss of specific lineage markers, we determined whether Bcl11b 
deletion in ILC2s impaired N. brasiliensis clearance. However, 
because T cells are important for maintaining ILC2s during 
the later stages of N. brasiliensis clearance (Wong et al., 2012; 
Oliphant et al., 2014) and the Bcl11b/ chimeric mice have 
impaired T cell responses, we used a mixed chimera approach. 
We determined whether Bcl11b+/+ or Bcl11b/ FL could 
complement for the absence of ILC2ps in the BM of ILC2-
deficient mice infected with N. brasiliensis. The ILC2-deficient 
(Rorasg/floxIl7rCre/+) mice delete Rora in the lymphoid lineage, 
resulting in a loss of ILC2s without perturbing other hemato-
poietic lineages, thereby ensuring the continued presence of 
T cells (Oliphant et al., 2014).
Irradiated recipients were reconstituted with combinations 
of BM obtained from Roraflox/+ or Rorasg/flox mice carrying the 
Il7r-Cre allele (Schlenner et al., 2010) and Bcl11b+/+Id2gfp/+- or 
Bcl11b/Id2gfp/+-derived FL and infected with N. brasiliensis. 
Mice receiving the Roraflox/+Il7rCre/+ BM generated ILC2s 
Figure 3. ILC2s fail to develop in the absence of Bcl11b. (a–k) Flow 
cytometry was performed to enumerate the indicated cell populations  
in conditional Bcl11b-deficient mice (a–f) or chimeras generated using 
Bcl11b/ FL cells (g–k). (a and b) MLN ILC2s (a) and BM ILC2ps (b) in  
Cre-ERT2; Bcl11bflox/flox mice, treated as indicated (Veh, vehicle control; Tx, 
tamoxifen). Shown is mean ± SEM from two similar experiments with 
three to four mice per group. (c) Intracellular Gata3 staining in ILC2s from 
the MLNs of Cre-ERT2; Bcl11bflox/flox mice, treated as indicated. (d–f) MLN 
ILC2 (d), splenic CD3+ (e), and splenic NK1.1+ cells (f) after the administra-
tion of tamoxifen and IL-33 (+/ = Cre-ERT2; Bcl11b+/; flox/ = Cre-ERT2; 
Bcl11bflox/). Mean ± SEM from two similar experiments with two to three 
mice per group. (g) The indicated cell populations were enumerated in 
mice 6–8 wk after reconstitution with either Bcl11b+/+ or Bcl11b/ 
CD45.2+ FL, mixed with CD45.1+ BM. Bars represent mean ± SEM of five 
mice per group. Data represent three independent experiments. (h) ILC2s 
(linId2-gfp+ICOS+KLRG1+) in the MLN of mice reconstituted as in panel g, 
after PBS or IL-33 administration. (i–k) BM ILC2ps (linId2-gfp+Sca-1+ST2+; i), 
siLP ILC2s (linId2-gfp+KLRG1+) and NCR+ ILC3s (linId2-gfp+NKp46+; j) 
and MLN ILC2s and NCR+ ILC3s (k) in mice reconstituted as in panel g;  
(h–j) mean ± SEM; (k) mean ± SD. P-values refer to Student’s t test analysis:  
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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2008; Sonnenberg et al., 2011). Irradiated mice were reconsti-
tuted with either Bcl11b+/+ or Bcl11b/ FL before being 
challenged with C. rodentium. We observed no statistically sig-
nificant differences in the weights of Bcl11b+/+ or Bcl11b/ 
FL reconstituted mice 20+ d p.i. (Fig. 4 c), contrasting mark-
edly with the dramatic weight loss in Rag2/c/ mice 
(Fig. 4 d). Both groups also cleared the majority of bacteria by 
day 21 p.i. (Fig. 4 e). Notably, the frequency of NCR+ ILC3s was 
elevated in C. rodentium–infected Bcl11b/ FL-reconstituted 
mice as compared with controls (Fig. 4, f–h), whereas ILC2s 
were absent. Bcl11b deficiency also resulted in the modest 
expansion of a KLRG1loNKp46+ population, the etiology of 
which is unclear (Fig. 4 f). These results recapitulate the in-
crease in NCR+ ILC3 numbers we observed in naive Bcl11b-
deficient mice.
The specific downstream gene targets of Bcl11b in ILC2s 
remain to be identified, and ChIP-Seq is challenging because 
of the small numbers of ILC2s available and uncertainty as to 
the exact sequence of the endogenous Bcl11b-binding site. 
However, studies of the T cell differentiation pathway sug-
gest that Bcl11b can act as both a repressor and activator of 
transcription depending on its association with binding partners 
Rorasg/floxIl7rCre/+ BM plus Bcl11b+/+Id2gfp/+ FL rescued the 
ILC2-deficient phenotype caused by the production of ILC2s 
from the Bcl11b+/+Id2gfp/+ FL (Fig. 4 a), resulting in worm 
clearance similar to the control Roraflox/+ mice (Fig. 4 b). Strik-
ingly, Bcl11b/Id2gfp/+-derived FL reconstitution was unable 
to reverse the ILC2 deficiency (Fig. 4 a) and failed to efficiently 
clear N. brasiliensis by day 7 p.i. (Fig. 4 b). Thus, deletion of 
Bcl11b results in a critical loss of functional ILC2s, without 
which mice are unable to clear worm infection efficiently.
Bcl11b deficiency does not impair ILC3  
responses to Citrobacter rodentium
To investigate whether the absence of Bcl11b alters the func-
tional capacity of ILC3s, we used the C. rodentium infection 
model. C. rodentium is a bacterial pathogen of mice that is 
closely related to the clinically important human enteropatho-
genic and enterohemorrhagic E. coli. Infection of wild-type 
mice with C. rodentium causes modest and transient weight 
loss and diarrhea, with clearance of infection within 21–28 d. 
In contrast, mice lacking ILC3s fail to control C. rodentium 
infection in the gut, as the result of insufficient IL-22 produc-
tion, and succumb rapidly to infection (Satoh-Takayama et al., 
Figure 4. Bcl11b is essential for clearance of N. brasiliensis infection but not clearance of C. rodentium. (a–h) Bcl11b-deficient FL cells were 
used to generate chimeric mice that were either partially (ILC2s only; a and b) or fully deficient in Bcl11b (c–h). These chimeras were challenged with  
N. brasiliensis (a and b) or C. rodentium (c–h), and the indicated cell populations were enumerated by flow cytometry. (a and b) MLN ILC2 numbers (a) and 
intestinal worm burdens (b). Data represent two independent experiments with five to six mice per group; (a) mean ± SD; (b) mean ± SEM. (c and d) 
Weights after C. rodentium infection (single experiment with three mice per group; mean ± SD). (e) Bacterial load after C. rodentium infection (mean ± 
SEM). (f–h) Identification (f) and number (g) of ILC2 (linCD45+Id2-gfp+IL7R+KLRG1+), ILC3 (linCD45+Id2-gfp+IL7R+NKp46+ KLRG1; mean ± SD), and 
KLRG1lo cells (linCD45+Id2-gfp+IL7R+ NKp46+KLRG1lo) and intracellular staining of lineage cells in the siLP (h) at day 26 p.i. with C. rodentium. (c and 
e–h) Data represent two independent experiments with eight to nine mice per group. P-values refer to Student’s t test analysis: *, P < 0.05; **, P < 0.01; 
***, P < 0.001.
JEM Vol. 212, No. 6 881
Br ief Definit ive Repor t
(C398.4A), anti-CD3e (145-2C11), anti-CD11b (M1/70), anti–IL-7R 
(SB/199), and anti-FcRI (MAR-1) were purchased from BioLegend. 
Anti-CD5 (53-7.3) was purchased from BD. Anti-T1/ST2 (DJ8) conjugated 
to biotin was purchased from MD Biosciences. All isotype control antibodies, 
rat anti–mouse IgG1, IgG2a, IgG2b, and Armenian hamster anti–mouse IgG 
were purchased from eBioscience.
IL-25 and IL-33 administration. rmIL-25 (0.5 µg per dose; Centocor) 
was administered daily for up to 4 d by intraperitoneal injection. rmIL-
33 (0.5 µg per dose; BioLegend) was administered daily for 3 d by intra-
peritoneal injection or for 3 d (0.25 µg per dose) intranasally. Control 
mice received PBS only. Mice were euthanized 24 h after the final injec-
tion and tissues collected for analysis. Tamoxifen (1 mg per dose) was 
administered intraperitoneally in 100 µl vehicle, containing 90% sun-
flower oil (Sigma-Aldrich) and 10% ethanol. Conditional Bcl11b-deficient 
(Bcl11bflox/) mice were treated with six doses of tamoxifen and analyzed 
3.5 wk later.
OP9-DL1 cultures. Cultures of ILC progenitor populations on OP9 and 
OP9-DL1 stroma (provided by J.C. Zúñiga-Pflücker, University of To-
ronto, Toronto, Ontario, Canada) were conducted as described previously 
(Wong et al., 2012).
Adoptive cell transfer. Putative ILC progenitor populations were FACS 
purified and collected into a 1:1 mixture of PBS and C57BL/6 mouse serum. 
Cells were injected directly into the tail vein of Rag2/c/ recipients 
(700 cells per recipient in a volume of 100 µl). Id2-gfp+ progeny were ana-
lyzed 3–6 wk after transfer.
Irradiation chimeras. Cell suspensions derived from embryonic day (E) 
15.5 FLs were frozen in RPMI supplemented with 25% FCS and 10% 
DMSO and thawed immediately before reconstitution. For mixed chimera 
experiments, lethally irradiated C57BL/6 (CD45.2+) recipients were recon-
stituted with Bcl11b+/+ or Bcl11b/ FL cells, either alone or as a 1:1 mix-
ture (1–4 × 106 cells) with BM derived from either B6SJL (CD45.1+) or 
IL7Rcre; Roraflox/ mice.
Infection models. For N. brasiliensis infection, mice were inoculated sub-
cutaneously with 500 viable third-stage larvae and euthanized 4–7 d p.i. Tis-
sues were collected for analysis, and small intestine worm burdens were 
enumerated using a dissection microscope (Wild M3Z; Leica). For C. roden-
tium infection, 100 ml LB broth containing 50 ng/ml nalidixic acid was in-
oculated with a single colony of C. rodentium (ICC180). Cultures were grown 
for 16 h at 37°C, with shaking, and then concentrated 10-fold in PBS. Mice 
were gavaged with 7 × 109 CFU C. rodentium in 100 µl PBS. Weights of 
mice were recorded over the infection time course, and fecal pellets were 
collected at the indicated time points to ascertain the bacterial load. Pellets 
were weighed and resuspended in 100 µl PBS per 0.01 g. Supernatants from 
homogenized pellets were serially diluted and plated onto LB agar plates 
supplemented with 50 ng/ml kanamycin. Colonies were enumerated after 
overnight incubation at 37°C.
Statistical analysis. Prism (GraphPad Software) was used to calculate the 
SEM when different numbers of datasets existed in each experimental group. 
Statistical differences between groups were calculated using Student’s t test, 
with P < 0.05 considered significant.
Online supplemental material. Flow cytometry gating strategies are de-
scribed in Figs. S1–S3. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20142224/DC1.
We thank Helen Jolin and the staff at Ares for their help, especially Angela 
Middleton, James Cruickshank, and Richard Berks. We also thank Juan Carlos 
Zúñiga-Pflücker for the OP9-DL1 cells.
(Liu et al., 2010) and on its state of phosphorylation or su-
moylation (Avram and Califano, 2014).
It has been proposed that Bcl11b lies downstream of 
Notch signals that regulate its expression during T cell differ-
entiation. We have reported previously that ILC2 develop-
ment also requires Notch signals (Wong et al., 2012), and it 
is possible that these signals differentially regulate Bcl11b ex-
pression in ILC2s and T cells as compared with NK cells and 
ILC3s. Indeed, Bcl11b/ DN2 thymocytes have been re-
ported to express elevated levels of ILC3 and NK-inducing 
genes (including Id2, Il2rb, Nfil3, and Plzf), suggesting that 
these genes may be de-repressed in the absence of Bcl11b (Li 
et al., 2010a). However, it is not clear that a simple dominant 
master transcriptional regulator explains these differentiation 
pathways, and it is likely that the ILC and T cell transcription 
factor circuitry will share rheostats and resistors that are tem-
porally and spatially regulated.
Collectively, these findings reveal a novel Bcl11b-mediated 
mechanism for the generation of ILC2s and demonstrate that 
this transcription factor is essential for ILC2 development and 
their functional role in helminth immunity. It is also note-
worthy that mutations, duplications, and rearrangements in 
BCL11B are found in human hematological malignancies, 
including T cell acute lymphoblastic leukemia (T-ALL; Liu 
et al., 2010; Huang et al., 2012). The identification of a new 
role for Bcl11b in mouse ILC2 development raises the ques-
tion of whether BCL11B acts in a similar way in human 
ILC2s and if the mutations in BCL11B may result in, as yet 
unidentified, ILC2 leukemia.
MATERIALS AND METHODS
Mice. C57BL/6J, Id2gfp/+ (Jackson et al., 2011), Bcl11btom/+ (Li et al., 2010b), 
CreERT2;Bcl11bflox/ (Li et al., 2010b), IL7Rcre (Schlenner et al., 2010), 
Roraflox/ (Oliphant et al., 2014), B6SJL, and Rag2/c/ (Colucci et al., 
1999) were all on a C57BL/6 background and bred in a specific pathogen–
free facility. In individual experiments, all mice were matched for age, gen-
der, and background strain. All animal experiments undertaken in this study 
were done so with the approval of the UK Home Office.
Antibodies and flow cytometry. Mouse tissue cell suspensions were in-
cubated with purified anti-Fc receptor blocking antibody (anti-CD16/
CD32) before addition of the specific antibodies. Cell surface markers were 
stained using a combination of FITC-, PE-, PE-Cy7–, PerCP-Cy5.5– 
conjugated, allophycocyanin-conjugated, Alexa Fluor 647–conjugated, eFluor 
660–conjugated, eFluor 450–conjugated, Brilliant Violet 421–conjugated, 
Brilliant Violet 510–conjugated, Brilliant Violet 650–conjugated APC-Cy7–
conjugated, and biotin-conjugated monoclonal antibodies. A cell viability 
marker was included to exclude dead cells from subsequent analysis. In each 
experiment, the appropriate isotype control monoclonal antibodies and sin-
gle conjugate controls were also included. Samples were analyzed using an 
LSRFortessa flow cytometer running FACSDiva acquisition (BD) and ana-
lyzed using FlowJo software (version 9.6.1; Tree Star). Cells were sorted 
using an iCyt Synergy cell sorter (Sony).
Antibodies for flow cytometry analysis included primary antibodies anti-
CD4 (GK1.5), anti-CD8a (53-6.7), anti-CD19 (1D3), anti–Gr-1 (RB6-8C5), 
anti-CD11c (N418), anti-TER119 (TER-119), anti-CD25 (PC61.5), anti-
CD44 (1M7), anti-CD45.1 (A20), anti-CD45.2 (104), anti-NK1.1 (PK136), 
anti-KLRG1 (2F1), fixable viability dye eFluor 780, and unconjugated anti-
CD16/32 (93) and were purchased from eBioscience. Streptavidin conju-
gated to PE, PE-Cy7, or AF647 was purchased from eBioscience. Anti-ICOS 
882 Bcl11b is essential for ILC2 development | Walker et al.
Liu, P., P. Li, and S. Burke. 2010. Critical roles of Bcl11b in T-cell develop-
ment and maintenance of T-cell identity. Immunol. Rev. 238:138–149. 
http://dx.doi.org/10.1111/j.1600-065X.2010.00953.x
McKenzie, A.N., H. Spits, and G. Eberl. 2014. Innate lymphoid cells in 
inflammation and immunity. Immunity. 41:366–374. http://dx.doi.org/ 
10.1016/j.immuni.2014.09.006
Mjösberg, J.M., S. Trifari, N.K. Crellin, C.P. Peters, C.M. van Drunen, B. 
Piet, W.J. Fokkens, T. Cupedo, and H. Spits. 2011. Human IL-25- and 
IL-33-responsive type 2 innate lymphoid cells are defined by expression 
of CRTH2 and CD161. Nat. Immunol. 12:1055–1062. http://dx.doi 
.org/10.1038/ni.2104
Molofsky, A.B., J.C. Nussbaum, H.E. Liang, S.J. Van Dyken, L.E. Cheng, 
A. Mohapatra, A. Chawla, and R.M. Locksley. 2013. Innate lymphoid 
type 2 cells sustain visceral adipose tissue eosinophils and alternatively 
activated macrophages. J. Exp. Med. 210:535–549. http://dx.doi.org/ 
10.1084/jem.20121964
Moro, K., T. Yamada, M. Tanabe, T. Takeuchi, T. Ikawa, H. Kawamoto, J. 
Furusawa, M. Ohtani, H. Fujii, and S. Koyasu. 2010. Innate production 
of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid 
cells. Nature. 463:540–544. http://dx.doi.org/10.1038/nature08636
Neill, D.R., S.H. Wong, A. Bellosi, R.J. Flynn, M. Daly, T.K. Langford, C. 
Bucks, C.M. Kane, P.G. Fallon, R. Pannell, et al. 2010. Nuocytes rep-
resent a new innate effector leukocyte that mediates type-2 immunity. 
Nature. 464:1367–1370. http://dx.doi.org/10.1038/nature08900
Oliphant, C.J., Y.Y. Hwang, J.A. Walker, M. Salimi, S.H. Wong, J.M. Brewer, 
A. Englezakis, J.L. Barlow, E. Hams, S.T. Scanlon, et al. 2014. MHCII-
mediated dialog between group 2 innate lymphoid cells and CD4+ T cells 
potentiates type 2 immunity and promotes parasitic helminth expulsion. 
Immunity. 41:283–295. http://dx.doi.org/10.1016/j.immuni.2014.06.016
Price, A.E., H.E. Liang, B.M. Sullivan, R.L. Reinhardt, C.J. Eisley, D.J. Erle, 
and R.M. Locksley. 2010. Systemically dispersed innate IL-13–expressing 
cells in type 2 immunity. Proc. Natl. Acad. Sci. USA. 107:11489–11494. 
http://dx.doi.org/10.1073/pnas.1003988107
Satoh-Takayama, N., C.A. Vosshenrich, S. Lesjean-Pottier, S. Sawa, M. Lochner, 
F. Rattis, J.J. Mention, K. Thiam, N. Cerf-Bensussan, O. Mandelboim, 
et al. 2008. Microbial flora drives interleukin 22 production in intestinal 
NKp46+ cells that provide innate mucosal immune defense. Immunity. 
29:958–970. http://dx.doi.org/10.1016/j.immuni.2008.11.001
Schlenner, S.M., V. Madan, K. Busch, A. Tietz, C. Läufle, C. Costa, C. 
Blum, H.J. Fehling, and H.R. Rodewald. 2010. Fate mapping reveals 
separate origins of T cells and myeloid lineages in the thymus. Immunity. 
32:426–436. http://dx.doi.org/10.1016/j.immuni.2010.03.005
Sonnenberg, G.F., L.A. Monticelli, M.M. Elloso, L.A. Fouser, and D. Artis. 
2011. CD4+ lymphoid tissue-inducer cells promote innate immunity 
in the gut. Immunity. 34:122–134. http://dx.doi.org/10.1016/j.immuni 
.2010.12.009
Stanya, K.J., D. Jacobi, S. Liu, P. Bhargava, L. Dai, M.R. Gangl, K. Inouye, 
J.L. Barlow, Y. Ji, J.P. Mizgerd, et al. 2013. Direct control of hepatic 
glucose production by interleukin-13 in mice. J. Clin. Invest. 123:261–
271. http://dx.doi.org/10.1172/JCI64941
Wakabayashi, Y., H. Watanabe, J. Inoue, N. Takeda, J. Sakata, Y. Mishima, 
J. Hitomi, T. Yamamoto, M. Utsuyama, O. Niwa, et al. 2003. Bcl11b 
is required for differentiation and survival of  T lymphocytes. Nat. 
Immunol. 4:533–539. http://dx.doi.org/10.1038/ni927
Walker, J.A., J.L. Barlow, and A.N. McKenzie. 2013. Innate lymphoid 
cells—how did we miss them? Nat. Rev. Immunol. 13:75–87. http://dx 
.doi.org/10.1038/nri3349
Wong, S.H., J.A. Walker, H.E. Jolin, L.F. Drynan, E. Hams, A. Camelo, 
J.L. Barlow, D.R. Neill, V. Panova, U. Koch, et al. 2012. Transcription 
factor ROR is critical for nuocyte development. Nat. Immunol. 13:229–
236. http://dx.doi.org/10.1038/ni.2208
Yagi, R., C. Zhong, D.L. Northrup, F. Yu, N. Bouladoux, S. Spencer, G.  
Hu, L. Barron, S. Sharma, T. Nakayama, et al. 2014. The transcription 
factor GATA3 is critical for the development of all IL-7R-expressing 
innate lymphoid cells. Immunity. 40:378–388. http://dx.doi.org/10.1016/ 
j.immuni.2014.01.012
This work was supported by the American Asthma Foundation, UK-MRC, and 
Wellcome Trust (grant number 100963/Z/13/Z; A.N.J. McKenzie); and Science 
Foundation Ireland and National Children’s Research Centre (P.G. Fallon).
The authors declare no competing financial interests.
Author contributions: J.A. Walker, A. Englezakis, C.J. Oliphant, S. Clare, and Y. Yu 
performed the experiments. H.-R. Rodewald, G. Belz, P. Liu, and P.G. Fallon provided 
critical reagents and advice. A.N.J. McKenzie conceived the project and wrote the 
manuscript with J.A. Walker.
Submitted: 28 November 2014
Accepted: 14 April 2015
REFERENCES
Avram, D., and D. Califano. 2014. The multifaceted roles of Bcl11b in 
thymic and peripheral T cells: impact on immune diseases. J. Immunol. 
193:2059–2065. http://dx.doi.org/10.4049/jimmunol.1400930
Barlow, J.L., R.J. Flynn, S.J. Ballantyne, and A.N. McKenzie. 2011. 
Reciprocal expression of IL-25 and IL-17A is important for allergic 
airways hyperreactivity. Clin. Exp. Allergy. 41:1447–1455. http://dx.doi 
.org/10.1111/j.1365-2222.2011.03806.x
Carotta, S., S.H. Pang, S.L. Nutt, and G.T. Belz. 2011. Identification of the 
earliest NK-cell precursor in the mouse BM. Blood. 117:5449–5452. 
http://dx.doi.org/10.1182/blood-2010-11-318956
Chang, Y.J., H.Y. Kim, L.A. Albacker, N. Baumgarth, A.N. McKenzie, 
D.E. Smith, R.H. Dekruyff, and D.T. Umetsu. 2011. Innate lymphoid 
cells mediate influenza-induced airway hyper-reactivity independently 
of adaptive immunity. Nat. Immunol. 12:631–638. http://dx.doi.org/10 
.1038/ni.2045
Colucci, F., C. Soudais, E. Rosmaraki, L. Vanes, V.L. Tybulewicz, and J.P. 
Di Santo. 1999. Dissecting NK cell development using a novel alym-
phoid mouse model: investigating the role of the c-abl proto-oncogene 
in murine NK cell differentiation. J. Immunol. 162:2761–2765.
Diefenbach, A., M. Colonna, and S. Koyasu. 2014. Development, differen-
tiation, and diversity of innate lymphoid cells. Immunity. 41:354–365. 
http://dx.doi.org/10.1016/j.immuni.2014.09.005
Halim, T.Y., A. MacLaren, M.T. Romanish, M.J. Gold, K.M. McNagny, 
and F. Takei. 2012. Retinoic-acid-receptor-related orphan nuclear re-
ceptor alpha is required for natural helper cell development and aller-
gic inflammation. Immunity. 37:463–474. http://dx.doi.org/10.1016/ 
j.immuni.2012.06.012
Hams, E., R.M. Locksley, A.N. McKenzie, and P.G. Fallon. 2013. Cutting 
edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that 
regulate obesity in mice. J. Immunol. 191:5349–5353. http://dx.doi.org/ 
10.4049/jimmunol.1301176
Hoyler, T., C.S. Klose, A. Souabni, A. Turqueti-Neves, D. Pfeifer, E.L. 
Rawlins, D. Voehringer, M. Busslinger, and A. Diefenbach. 2012. 
The transcription factor GATA-3 controls cell fate and maintenance 
of type 2 innate lymphoid cells. Immunity. 37:634–648. http://dx.doi 
.org/10.1016/j.immuni.2012.06.020
Huang, X., X. Du, and Y. Li. 2012. The role of BCL11B in hematologi-
cal malignancy. Exp. Hematol. Oncol. 1:22. http://dx.doi.org/10.1186/ 
2162-3619-1-22
Jackson, J.T., Y. Hu, R. Liu, F. Masson, A. D’Amico, S. Carotta, A. Xin, 
M.J. Camilleri, A.M. Mount, A. Kallies, et al. 2011. Id2 expression de-
lineates differential checkpoints in the genetic program of CD8+ and 
CD103+ dendritic cell lineages. EMBO J. 30:2690–2704. http://dx.doi 
.org/10.1038/emboj.2011.163
Li, L., M. Leid, and E.V. Rothenberg. 2010a. An early T cell lineage com-
mitment checkpoint dependent on the transcription factor Bcl11b. 
Science. 329:89–93. http://dx.doi.org/10.1126/science.1188989
Li, P., S. Burke, J. Wang, X. Chen, M. Ortiz, S.C. Lee, D. Lu, L. Campos, 
D. Goulding, B.L. Ng, et al. 2010b. Reprogramming of T cells to nat-
ural killer–like cells upon Bcl11b deletion. Science. 329:85–89. http://
dx.doi.org/10.1126/science.1188063
